Drug Type Small molecule drug |
Synonyms (2S)-2-Aminopentanedioic acid, (S)-2-Aminopentanedioic acid, (S)-Glutamic acid + [12] |
Target |
Mechanism GRIA2 agonists(glutamate ionotropic receptor AMPA type subunit 2 agonists), Amino acid replacements |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC5H9NO4 |
InChIKeyWHUUTDBJXJRKMK-VKHMYHEASA-N |
CAS Registry56-86-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00007 | Glutamic Acid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatic Encephalopathy | CN | - | - |
Phase 3 | 250 | (Arm I Glutamic Acid) | ykhustkqov(waqnyqakwl) = xpxhmxfdsl ouzoevuvmf (byfiiieegl, zdwykxkfui - yxfegpbrfy) View more | - | 14 Mar 2014 | ||
placebo (Arm II Placebo) | ykhustkqov(waqnyqakwl) = olkbjaplfg ouzoevuvmf (byfiiieegl, ttqgpghiac - rmkbtxqzrr) View more |